SE7904118L - Sett att framstella en urokinaskomposition - Google Patents

Sett att framstella en urokinaskomposition

Info

Publication number
SE7904118L
SE7904118L SE7904118A SE7904118A SE7904118L SE 7904118 L SE7904118 L SE 7904118L SE 7904118 A SE7904118 A SE 7904118A SE 7904118 A SE7904118 A SE 7904118A SE 7904118 L SE7904118 L SE 7904118L
Authority
SE
Sweden
Prior art keywords
urokinase
injection
urokina
prepare
composition
Prior art date
Application number
SE7904118A
Other languages
English (en)
Swedish (sv)
Inventor
Y Yamahira
K Fujioka
Y Okuzawa
S Miura
S Sato
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of SE7904118L publication Critical patent/SE7904118L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7904118A 1978-05-12 1979-05-10 Sett att framstella en urokinaskomposition SE7904118L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5682678A JPS54147916A (en) 1978-05-12 1978-05-12 Preparation of urokinase injection

Publications (1)

Publication Number Publication Date
SE7904118L true SE7904118L (sv) 1979-11-13

Family

ID=13038173

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7904118A SE7904118L (sv) 1978-05-12 1979-05-10 Sett att framstella en urokinaskomposition

Country Status (10)

Country Link
US (1) US4244943A (da)
JP (1) JPS54147916A (da)
CA (1) CA1115206A (da)
CH (1) CH641046A5 (da)
DE (1) DE2917899A1 (da)
DK (1) DK147812B (da)
FR (1) FR2425245A1 (da)
GB (1) GB2021412B (da)
IT (1) IT7949032A0 (da)
SE (1) SE7904118L (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813521A (ja) * 1981-07-16 1983-01-26 Green Cross Corp:The ミエロペルオキシダ−ゼの粉末製剤
US4350659A (en) * 1981-07-30 1982-09-21 Corning Glass Works Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
JPS59139323A (ja) * 1983-01-28 1984-08-10 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
SU1128601A1 (ru) * 1983-05-10 1985-07-15 Всесоюзный кардиологический научный центр АМН СССР Урокиназа,иммобилизированна на фибриногене
JPS6051119A (ja) * 1983-08-30 1985-03-22 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS61111684A (ja) * 1984-11-05 1986-05-29 Terumo Corp 精製されたウロキナ−ゼ複合体の製造方法
JPS61124383A (ja) * 1984-11-16 1986-06-12 Unitika Ltd 固定化線維素溶解活性酵素の安定化法
AU576047B2 (en) * 1985-01-14 1988-08-11 Shiseido Company Ltd. Fibrinophilic urokinase complex and process for its preparation
CA1336585C (en) * 1985-04-16 1995-08-08 Kazuo Morimoto Method of stabilizing urokinase precursor and dry preparation containing said precursor
JPS61238732A (ja) * 1985-04-16 1986-10-24 Green Cross Corp:The ウロキナーゼ前駆体乾燥製剤
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
WO1990001334A1 (en) * 1988-08-05 1990-02-22 Codon Formulations for plasminogen activator using aspartate
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤
AU635541B2 (en) * 1989-05-17 1993-03-25 Research Corporation Technologies, Inc. Method and composition for the treatment of thrombosis in a mammal
DE69012675T2 (de) * 1989-06-30 1995-05-04 Ucar Carbon Tech Graphitfolie.
USD403943S (en) 1997-01-24 1999-01-12 Peter James Curry Detachable hand grip tool
EP2236617A1 (en) * 2009-03-31 2010-10-06 Leukocare Ag Methods of terminal sterilization of biofunctional compositions
BR112012027361A2 (pt) * 2010-04-27 2021-04-27 Scil Technology Gmbh formulação mia/cd-rap estável.
CN104906054B (zh) * 2015-06-15 2017-08-25 武汉人福药业有限责任公司 一种尿激酶冻干剂的制备方法
CN111450052A (zh) * 2020-04-22 2020-07-28 南京南大药业有限责任公司 一种尿激酶注射液制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (da) * 1963-12-23 1965-12-08
JPS5137343B2 (da) * 1972-12-07 1976-10-15

Also Published As

Publication number Publication date
CA1115206A (en) 1981-12-29
JPS54147916A (en) 1979-11-19
CH641046A5 (de) 1984-02-15
DK147812B (da) 1984-12-17
GB2021412A (en) 1979-12-05
GB2021412B (en) 1982-08-25
DE2917899A1 (de) 1979-11-22
DK195079A (da) 1979-11-13
FR2425245B1 (da) 1983-03-11
IT7949032A0 (it) 1979-05-11
US4244943A (en) 1981-01-13
FR2425245A1 (fr) 1979-12-07

Similar Documents

Publication Publication Date Title
SE7904118L (sv) Sett att framstella en urokinaskomposition
SE8101065L (sv) Antitrombinberedning
DK160459C (da) Fremgangsmaade til fremstilling af denatureringsbestandige vandige proteinoploesninger
DK151623C (da) Analogifremgangsmaade til fremstilling af n-substituerede moranolinderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149111C (da) Analogifremgangsmaade til fremstilling af histidinderivater eller syreadditionssalte deraf
ES416597A1 (es) Procedimiento de preparacion de albumina purificada.
MX6015E (es) Procedimiento para la preparacion de composiciones de globulina de suero inmune,altamente estabilizada
NO150106C (no) Anvendelse av en n-acyl-alfa-aminosyre som emulgeringsmiddel for fremstilling av emulsjoner
DK147858C (da) Analogifremgangsmaade til fremstilling af 5'-deoxy-5-fluorcytidin eller 5'-deoxy-5-fluoruridin eller fysiologisk tolerable syreadditionssalte dera
ES483638A0 (es) Un procedimiento para la preparacion de un substituto de la-leche.
DK148183A (da) Fremgangsmaade til fremstilling af imidazolylphenyl-tetrahydropyridaziner
ES8505518A1 (es) Procedimiento para preparar derivados de aminoacidos
BG44537A3 (en) Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate
BG30324A3 (bg) Метод за получаване на 4-субституирани тиазолоксамови киселини, техни соли и естери
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
SE7904742L (sv) Stabiliserade mjolkproteinhaltiga kompositioner
PT71408A (de) Verfahren zur herstellung von 1-alkadien-2,4-yl-2-hidroxymethyl-3,4,5-trimydroxypiperidinen mit wirkung uber die kohlehydraten und/oder fettwechsel und von diesen verbindungen enthaltenden pharmazeutischen und/oder tierartzleichen praparaten
SE7609443L (sv) Sett att framstella ett stabilt farmaceutiskt preparat
GB1518568A (en) Process for the preparation of concentrated suspensions of pesticides
DK160310C (da) Analogifremgangsmaade til fremstilling af 6-oe(cyclisk amino)ethylaminoaatetrahydrotriazolooe3,4-aaaphthalaziner eller farmaceutisk acceptable syreadditionssalte deraf
SE7907986L (sv) Sett att framstella 3alfa,7beta-dihydroxicholansyra
DK149750C (da) Analogifremgangsmaade til fremstilling af n-alkenylmoranolin-derivater eller farmaceutiske acceptable syreadditionssalte deraf
DK247279A (da) Fremgangsmaade til fremstilling af carbazolderivater
GB1077249A (en) A new amine and process for its manufacture
YU46319B (sh) Postupak za dobijanje 1-/3-merkapto-/2s/-metilpropionil/-pirolidin-/2s/-karboksilne kiseline

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7904118-2